Cargando…
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
Yellow fever virus (YFV) is a member of the Flaviviridae family. In Brazil, yellow fever (YF) cases have increased dramatically in sylvatic areas neighboring urban zones in the last few years. Because of the high lethality rates associated with infection and absence of any antiviral treatments, it i...
Autores principales: | de Freitas, Caroline S., Higa, Luiza M., Sacramento, Carolina Q., Ferreira, André C., Reis, Patrícia A., Delvecchio, Rodrigo, Monteiro, Fabio L., Barbosa-Lima, Giselle, James Westgarth, Harrison, Vieira, Yasmine Rangel, Mattos, Mayara, Rocha, Natasha, Hoelz, Lucas Villas Bôas, Leme, Rennan Papaleo Paes, Bastos, Mônica M., L. Rodrigues, Gisele Olinto, M. Lopes, Carla Elizabeth, Queiroz-Junior, Celso Martins, Lima, Cristiano X., Costa, Vivian V., Teixeira, Mauro M., Bozza, Fernando A., Bozza, Patrícia T., Boechat, Nubia, Tanuri, Amilcar, Souza, Thiago Moreno L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375661/ https://www.ncbi.nlm.nih.gov/pubmed/30699122 http://dx.doi.org/10.1371/journal.pntd.0007072 |
Ejemplares similares
-
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
por: Ferreira, André C., et al.
Publicado: (2017) -
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
por: Sacramento, Carolina Q., et al.
Publicado: (2017) -
Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
por: Sacramento, Carolina Q., et al.
Publicado: (2017) -
Pyrroles as Privileged Scaffolds in the Search for New Potential HIV Inhibitors
por: Bianco, Maria da Conceição Avelino Dias, et al.
Publicado: (2021) -
Dengue induces iNOS expression and nitric oxide synthesis in platelets through IL-1R
por: Pinheiro, Mariana Brandi Mendonça, et al.
Publicado: (2022)